Intellectual Property News & Topics - Secerna LLP

Morning Sickness Drugs Repurposing

Morning Sickness: The Role of Drug Repurposing and Intellectual Property Considerations

News 17/09/2024

Recent breakthroughs in understanding the underlying causes of morning sickness offer exciting opportunities for drug repurposing. Learn how researchers can leverage existing medications to develop innovative treatments for this common pregnancy symptom.

Read more

Untitled Design 2023 02 10T100130.018

News 15/12/2022

Intrepid explorer sets off to “Seas the Day”

Surgeon

European, Industry news 01/12/2022

New Developments in MedTech Patenting at the European Patent Office

Dermot Roche Press 800X800px Colour Temp Pic

European, Events, Team news 23/11/2022

Secerna to attend Knowledge Transfer Ireland Impact Awards

European Patent Office Building

European, Industry news 08/11/2022

How To Make Life Easier At The EPO – Exclusion of Diagnostic Methods

EPO 2021

European, Industry news 01/11/2022

Plausibility at the EPO - G2/21

B012799

Events 16/10/2022

Oncology & Precision Medicine Conferences 2022

News234

Industry news 14/10/2022

Pushing the boundaries of scientific discovery

News232

European 05/10/2022

Patenting Antibodies at the European Patent Office

News231

Team news 27/09/2022

Biotech specialist joins growing Yorkshire IP law firm

10 11 12 13 14 15 16 17 18 19 20